Yariv Mazor

1.8k citations
24 papers · 1.3k indexed · h-index 16

Yariv Mazor

24 papers receiving 1.2k citations

Peers

Yariv Mazor
Comparison fields: 5 of 71
  • Radiology, Nuclear Medicine and Imaging 669
  • Molecular Biology 860
  • Immunology 236
  • Biomaterials 140
  • Physiology 261
Replace Makoto Nakakido with:
Makoto Nakakido Japan
Tilman Schlothauer Germany
Simon E. Hufton Netherlands
Dorothea Reilly United States
Martin Dalziel United Kingdom
Thomas L. Ciardelli United States
Noritaka Hashii Japan
Katrine T. Schjoldager Denmark
Lionel Rougé France
Ewa Pol Sweden
Yariv Mazor relative to Makoto Nakakido Japan Makoto Nakakido's profile →
Citations per field
00.5×4.7×
Makoto Nakakido · 1×
Citations per year

Countries citing papers authored by Yariv Mazor

Since Specialization
Citations

This map shows the geographic impact of Yariv Mazor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yariv Mazor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yariv Mazor more than expected).

Fields of papers citing papers by Yariv Mazor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yariv Mazor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yariv Mazor. The network helps show where Yariv Mazor may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yariv Mazor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yariv Mazor Line = papers co-authored together Yariv Mazor links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20232
2 20225
3 20212
4 201939
5 201789
6 201635
7 2015108
8 201511
9 201561
10 201518
11 201033
12 201027
13 200839
14 20088
15 200719
16 200754
17 200412
18 2004199
19 2002170
20 2001153

About Yariv Mazor

Yariv Mazor is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Oncology, having authored 24 papers that have together received 1.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (19 papers), Glycosylation and Glycoproteins Research (10 papers), Protein purification and stability (5 papers), Bacteriophages and microbial interactions (5 papers), CAR-T cell therapy research (5 papers), Advanced Biosensing Techniques and Applications (3 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (669 citations), Molecular Biology (860 citations) and Immunology (236 citations). Yariv Mazor has collaborated with scholars based in United States, Israel and Germany. Frequent co-authors include Ehud Gazit, Itai Benhar, George Georgiou, Shimon Efrat, Yair Porat, Thomas Van Blarcom, Sharon Gilead, Herren Wu, Chunning Yang and Brent L. Iverson. Their work appears in journals such as mAbs, Journal of Molecular Biology, Journal of Immunological Methods, PLoS ONE and Biotechnology and Bioengineering.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026